Glycosylation of an immunoglobulin produced from a murine hybridoma cell line: The effect of culture mode and the anti-apoptotic gene, bcl-2

Biotechnology and Bioengineering

Volumn 97, Issue 1, 2007, Pages 156-169

  Majid, F A A ^a   Butler, M ^b   Al Rubeai, M ^a,c  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b UNIVERSITY OF MANITOBA   (Canada)

^c UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

Apoptosis; Bcl 2; Cell culture; Galactosylation; Glycosylation; Hybridoma; IgG

Indexed keywords

CELL CULTURE; CELL DEATH; GENES; IMMUNOLOGY; OLIGOSACCHARIDES; PROTEINS;

CULTURE MODES; GALACTOSYLATION; GLYCANS; HYBRIDOMA;

GLYCOSYLATION;

GLYCAN; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; OLIGOSACCHARIDE; PROTEIN BCL 2;

ANIMAL CELL; APOPTOSIS; ARTICLE; BIOREACTOR; CELL DEATH; CELL FRACTIONATION; CELL GROWTH; CELL VIABILITY; CHEMOSTAT; CONTROLLED STUDY; GENE OVEREXPRESSION; GLYCOSYLATION; HYBRIDOMA CELL CULTURE; NONHUMAN;

ANIMALS; APOPTOSIS; CELL CULTURE TECHNIQUES; CELL LINE; CELL SURVIVAL; GLYCOSYLATION; HYBRIDOMAS; HYDROXYLATION; IMMUNOGLOBULIN G; MICE; PROTO-ONCOGENE PROTEINS C-BCL-2; RECOMBINANT PROTEINS;

MURINAE;

EID: 34247528468     PISSN: 00063592     EISSN: 10970290     Source Type: Journal    
DOI: 10.1002/bit.21207     Document Type: Article

References (58)

1. Al-Rubeai M. 1998. Apoptosis and cell culture technology. Adv Biochem Eng/Biotech 59:225-249.
2. Al-Rubeai M, Emery AN. 1990. Mechanisms and kinetics of monoclonal antibody synthesis and secretion in synchronous and asynchronous hybridoma cell cultures. J Biotechnol 16:67-85.
3. Al-Rubeai M, Singh S. 1998. Apoptosis in cell culture. Curr Opin Biotechnol 9:152-156.
4. Al-Rubeai M, Mills D, Emery AN. 1990. Electron microscopy of hybridoma cells with special regard to monoclonal antibody production. Cytotechnology 4:13-28.
5. Andersen DC, Goochee CF. 1994. The effect of cell culture conditions on the oligosaccharide structures of secreted glycoproteins. Curr Opin Biotechnol 5:546-549.
6. Arden N, Betenbaugh MJ. 2004. Life and death in mammalian cell culture: Strategies for apoptosis inhibition. Trends Biotechnol 22:174-180.
7. Bierau H, Perani A, Al-Rubeai M, Amery AN. 1998. A comparative of intensive cell culture bioreactors operating with hybridoma modified for inhibited apoptotic response. J Biotechnol 62:195-207.
8. Butler M. 2005. Animal cell cultures: Recent achievements and perspectives in the production of biopharmaceuticals. Appl Microbiol Biotechnol 68:283-291.
9. Cabrera G, Cremata JA, Valdes R, Garcia R, Gonzalez Y, Montesino R, Gomez H, Gonzalez M. 2005. Influence of culture conditions on the N-glycosylation of a monoclonal antibody specific for recombinant hepatitis B surface antigen. Biotechnol Appl Biochem 41:67-76.
10. Deisenhofer J. 1981. Crystallographic refinement and atomic models of human Fc fragment and its complex with fragment B of protein A from Staphylococcus aureus at 2.9 and 2.8A resolution. Biochem 20:2361-2370.
11. Fassnacht D, Rossing S, Franek F, Al Rubeai M, Portner R. 1998. Effect of bcl-2 expression on hybridoma cell growth in serum supplemented, protein free and diluted media. Cytotechnol 26:219-225.
12. Fassnacht D, Rossing S, Singh RP, Al-Rubeai M, Portner R. 1999. Influence of bcl-2 on antibody productivity in high cell density perfusion cultures of hybridoma. Cytotechnol 30:95-105.
13. Goswami J, Sinskey AJ, Stephanopoulos GN, Wang DIC. 1999. Apoptosis in batch cultures of Chinese hamster ovary cells. Biotechnol Bioeng 62:632-640.
14. Hardy MR, Townsend RR. 1994. High-pH anion-exchange chromatography of glycoprotein-derived carbohydrates. Methods Enzymol 230:208-225.
15. Hayter PM, Curling EK, Baines AJ, Jenkins N, Salmon I, Strange PG, Tong JM, Bull AT. 1992. Glucose limited chemostat culture of Chinese hamster ovary cells producing recombinant human interferon-gamma. Biotechnol Bioeng 39:327-335.
16. Hooker AD, Goldman MR, Markham NH, James DC, Ison AP, Bull AT, Salmon PG, Baines L, Jenkins N. 1995. N-Glycans of recombinant human Interferon-y changed during batch culture of Chinese hamster ovary cells. Biotechnol Bioeng 48:639-648.
17. Itoh Y, Euda H, Suzuki E. 1995. Over-expression of Bcl-2, apoptosis suppressing gene: Prolonged viable culture by hybridoma and enhanced antibody production. Biotechnol Bioeng 48:118-122.
18. Jefferis R. 2005. Glycosylation of recombinant antibody therapeutics. Biotechnol Prog 21:11-16.
19. Jefferis R, Lund J, Mizutani H, Nakagawa H, Kawazoe Y, Arata Y, Takahashi N. 1990. A comparative study of the N-linked oligosaccharide structures of human IgG subclass proteins. Biochem J 268:529-537.
20. Jenkins N, Curling EM. 1994. Glycosylation of recombinant proteins: Problems and prospects. Enzyme Microb Technol 16:354-364.
21. Kunkel JP, Jan DCK, Jamieson JC, Butler M. 1998. Dissolved oxygen concentration in serum-free continuous culture affects N-linked glycosylation of a monoclonal antibody. J Biotech 62:55-71.
22. Kuroda Y, Nakata M, Nose M, Kojima N, Mizuochi T. 2001. Abnormal IgG galactosylation and arthritis in MRL-Fas(lpr) or MRL-FasL(gld) mice are under the control of the MRL genetic background. FEBS Lett 507:210-214.
23. Kuroki A, Kuroda Y, Kikuchi S, Lajaunias F, Fulpius T, Pastore Y, Fossati-Jimack L, Reininger L, Toda T, Nakata M, Kojima N, Mizuochi T, Izui S. 2002. Level of galactosylation determines cryoglobulin activity of murine IgG3 monoclonal rheumatoid factor. Blood 99:2922-2928.
24. Leatherbarrow RJ, Dwek RA. 1983. The effect of aglycosylation on the binding of mouse IgG to staphylococcal protein A. FEBS Lett 164:227-230.
25. Lund J, Takahashi N, Nakagawa H, Goodall M, Bentley T, Hindley SA, Tyler R, Jefferis R. 1993. Control of IgG/Fc glycosylation: A comparison of oligosaccharides from chimeric human/mouse and mouse subclass immunoglobulin Gs. Mol Immunol 30:741-748.
26. 1bcl-2 transgenic mice. J Immunol 172:7177-7185.
27. Masuda K, Yamaguchi Y, Kato K, Takahashi N, Shimada I, Arata Y. 2000. Pairing of oligosaccharides in the Fc region of immunoglobulin G. FEBS Lett 473(3):349-357.
28. Mercille S, Massie B. 1994a. Induction of apoptosis in nutrient limited cultures in hybridoma cells. Biotech Bioeng 44:1140-1154.
29. Mercille S, Massie B. 1994b. Induction of apoptosis in oxygen deprived cultures of hybridoma, cells. Cytotechnol 15:117-128.
30. Mizuochi T, Hamako J, Titani K. 1987. Structures of the sugar chains of mouse immunoglobulin G. Arch Biochem Biophys 257:387-394.
31. Nahgrang S, Kragten E, De-Jeans M, Bourgeois M, Dejardins D, Von-Stockar U, Marison IW. 1999. The effect of cell line, transfection procedure and reactor condition on the glycosylation of recombinant human anti-rhesus D IgG1. In: Bernard A, et al., editors. Animal Cell Technology: Product from cells, cell as products. Dordrecht: Kluwer Academic Publishers. p 259-261.
32. Nose M, Wigzell H. 1983. Biological significance of carbohydrate chains on monoclonal antibodies. Proc Natl Acad Sci USA 80:6632-6636.
33. Nyberg GB, Balcarcel RR, Follstad BD, Stephanopoulos G, Wang DI. 1999. Metabolic effects on recombinant interferon-gamma glycosylation in continuous culture of Chinese hamster ovary cells. Biotechnol Bioeng 62:336-347.
34. Olsen CW, Kehren JC, Dybdahl-Sissoko NR, Hinshaw VS. 1996. bcl-2 alters influenza virus yield, spread, and hemagglutinin glycosylation. J Virol 70(1):663-666.
35. Parekh RB, Dwek RA, Sutton BJ, Fernandes DL, Leung A, Stanworth D, Rademacher TW, Mizuochi T, Taniguchi T, Matsuta K, Takeuchi F, Nagano Y, Miyamoto T, Kobata A. 1985. Association of rheumatoid arthritis and primary osteoarthritis with changes in the glycosylation pattern of total serum IgG. Nature 316(6027):452-457.
36. Patel TP, Parekh RB, Moellering BJ, Prior CP. 1992. Different culture methods lead to differences in glycosylation of a murine IgG monoclonal antibody. Biochem J 285:839-845.
37. Patterson MKJr.1979. Measurement of growth and viability of cells in culture. Methods Enzymol 58:141-152.
38. Perani A, Singh RP, Chauhan R, Al-Rubeai M. 1998. Variable functions of bcl-2 in mediating bioreactor stress induced apoptosis in hybridoma cells. Cytotechnol 28:117-188.
39. Raju TS, Briggs JB, Borge SM, Jones AJ. 2000. Species-specific variation in glycosylation of IgG: Evidence for the species-specific sialylation and branch-specific galactosylation and importance for engineering recombinant glycoprotein therapeutics. Glycobiology 10:477-486.
40. Renard JM, Spagnoli R, Mazier MF, Salles S, Mandine E. 1988. Evidence that monoclonal antibody production kinetics is related to the integral of the viable cells curve in batch system. Biotechnol Lett 10:91-96.
41. Restelli V, Butler M. 2002. The effect of cell culture parameters on protein glycosylation. In: Al-Rubeai M, editor. Cell Engineering Vol. 3: Glycosylation. Dordrecht: Kluwer publ. p 61-92.
42. Robinson DK, Seamans TC, Gould SL, DiStefano DJ, Chan CP, Lee DK, Bibila T, Glazomitsky K, Munshi S, Daugherty B. 1994. Optimization of a fed batch process for production of a recombinant antibody. Ann NY Acad Sci 745:285-296.
43. Routier FK, Hounsell EF, Rudd PM, Takahashi N, Bond A, Hay FC, Alavi A, Axford JS, Jefferis R. 1998. Quantification of the oligosaccharides of human serum IgG from patients with rheumatoid arthritis: A critical evaluation of different methods. J Immunol Methods 213:113-130.
44. Serrato JA, Palomares LA, Meneses-Acosta A, Ramirez OT. 2004. Heterogeneous conditions in dissolved oxygen affect N-glycosylation but not productivity of a monoclonal antibody in hybridoma cultures. Biotechnol Bioeng 88(2):176-188.
45. Sheeley DK, Merrill BM, Taylor LCE. 1997. Characterization of monoclonal antibody glycosylation: Comparison of expression systems and identification of terminal N-Linked Galactose. Ann Biochem 247:102-110.
46. Shikata K, Yasuda T, Takeuchi F, Konishi T, Nakata M, Mizuochi T. 1998. Structural changes in the oligosaccharide moiety of human IgG with aging. Glycoconj J 15:683-689.
47. Simpson NH, Milner AE, Al-Rubeai M. 1997. Prevention of hybridoma cell death by bcl-2 during sub-optimal culture conditions. Biotechnol Bioeng 54:1-16.
48. Simpson NK, Singh RP, Perani A, Goldenzon C, Al-Rubeai M. 1998. In hybridoma cultures, deprivation of any single amino acid leads to apoptotic death, which is suppressed by the expression of the bcl-2 gene. Biotechnol Bioeng 59:190-198.
49. Simpson NH, Singh RP, Emery AN, Al-Rubeai M. 1999. Bcl-2 overexpression reduces growth rate and prolongs GI phase in continuous chemostat cultures of hybridoma cells. Biotechnol Bioeng 64:2174-2186.
50. Singh RP, Al-Rubeai M, Gregory CD, Emery AN. 1994. Cell death in bioreactors. Role of apoptosis. Biotechnol Bioeng 44:720-726.
51. Singh RP, Emery AN, Al-Rubeai M. 1996. Enhancement of survivability of mammalian cells by over-expression of the apoptosis suppressor gene bcl-2. Biotech Bioeng 52:166-175.
52. Tey BT, Singh RP, Piredda L, Piacentini M, Al-Rubeai M. 2000a. Influence of bcl-2 over-expression on growth and productivity of a CHO cell line over-expressing a chimeric antibody. Biotechnol Bioeng 68:31-43.
53. Tey BT, Singh RP, Piredda L, Piacentini M, Al-Rubeai M. 2000b. Bcl-2 mediated suppression of apoptosis in myeloma, NSO cultures. J Biotechnol 79:147-159.
54. Walker MR, Lund J, Thompson KM, Jefferis R. 1989. Aglycosylation of human IgG1 and IgG3 monoclonal antibodies can eliminate recognition by human cells expressing FcγRI and/or FcγRII receptors. Biochem J 259:347-353.
55. Warner TG. 1999. Enhancing therapeutic glycoprotein production in Chinese hamster ovary cells by metabolic engineering endogenous gene control with anti-sense DNA and gene targeting. Glycobiology 9:841-850.
56. Warnock JN, Al-Rubeai M. 2006. Bioreactor systems for the production of biopharmaceuticals from animal cells. Biotechnol Appl Biochem 45:1-12.
57. Wurm FM. 2004. Production of recombinant protein therapeutics in cultivated mammalian cells. Nat Biotechnol 22:1393-1398.
58. Yang M, Butler M. 2000. The effect of ammonia on the glycosylation of human recombinant erythropoietin in culture. Biotech Prog 16:751-759.